产品详情
Cat#: 108P28
序列(三字母):H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH
序列(单字母):DRVYIHP
分子式:C₄₁H₆₂N₁₂O₁₁
分子量:899.02
CAS#:51833-78-4
合成方法:固相合成
存储条件:-20 ± 5 °C,避光,干燥
应用:Angiogenesis
Cancer Research
Cardiovascular System & Diseases
描述:Angiotensin (1-7), DRVYIHP, an enzymatically produced peptide of the renin-angiotensin system, shows pharmacologically distinct, tissue-specific actions that differ from those of angiotensin II.
Angiotensin (1-7) shows considerable cardiovascular and antiangiogenic activity. Iusuf et al. reviewed its phamacological properties and pharmacotherapeutic perspectives.
Moreover, the heptapeptide was shown to inhibit the growth of human lung cancer cells in vitro and to reduce the size of human lung cancer xenografts in vivo.
1)通过电话(+86-(0)-18115476705)邮件(sales@tgpeptide.com)联系我们;
2)提供合成多肽的具体需求,包括序列、质量和纯度,技术部门评估后给与报价。
3)签订多肽合成合同,交付合成预付款,科研机构先使用再付款!
4)合成过程定期跟您汇报合成进度及情况;
5)根据合同内容,随货提供发票;
6)如因本公司原因不能交货或合成失败,退还所有合成款!
Copyright ©2020 南京肽谷生物科技有限公司 备案号:苏ICP备19062824号-1 网站地图